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The formation of the myelin sheath in the CNS is the
endpoint of a defined developmental program along
which oligodendrocytes progress. However, the mo-
lecular signals required for the initiation of myelina-
tion are largely unknown. Ishibashi et al. report in
this issue of Neuron that ATP released by axons as
a result of electrical stimulation serves as an important
myelination signal. Surprisingly, they found that ATP
does not act directly on oligodendrocytes but rather
on astrocytes, causing the release of leukemia inhibi-
tory factor (LIF), which in turns affects promyelinating
oligodendrocytes. These findings uncover a novel role
for astrocytes in mediating the intricate communica-
tion between axons and myelinating glial cells.
Oligodendrocytes (OLs) form multiple myelin segments
by spirally wrapping their membrane around the axons,
thereby allowing efficient and rapid propagation of ac-
tion potentials. During development, oligodendrocytes
progress along a very precise differentiation program: ol-
igodendrocyte progenitor cells (OPCs) differentiate into
pre-oligodendrocytes and subsequently into immature
and promyelinated oligodendrocytes, which then can
myelinate axons. Although many of the factors affecting
oligodendrocyte development are known, little is known
about the mechanisms governing the onset of myelina-
tion. One factor that was suggested to be required for
myelination is electrical activity (Demerens et al., 1996).
This notion is further supported by the observations that
functional and cognitive activity, which are associated
with increased neuronal activity, results in correlative
changes in white matter tracks (reviewed in Fields, 2005).
Previous experiments have shown that adenosine, re-
leased at extrasynaptic sites upon electrical stimulation
of neurons, induces the differentiation of OPCs, eventu-
ally leading to an increase in myelination (Stevens et al.,
2002). Although the exact molecular mechanism is not
entirely clear, this effect was found to be mediated by
activation of purinergic receptors in OPCs. In the pres-
ent study, Ishibashi et al. went a step further and exam-
ined whether neuronal activity influences the ability of
more mature oligodendrocytes to myelinate (Ishibashi
et al., 2006 [this issue of Neuron]). The way they ap-
proached this question was to allow OPCs that were co-
cultured with DRG neurons to reach their mature pro-
myelinating stage before the neurons were stimulated.
The result was very clear: electrical activity of the neu-
rons promoted myelination of mature oligodendrocytes
through an activity-dependent release of ATP. Adeno-
sine, which regulated the proliferation and differentia-
tion of OPCs, had no affect on the ability of mature
oligodendrocytes to myelinate. Conversely, ATP only
affected mature oligodendrocytes, not their precursors,
suggesting that different signaling mechanisms are in-
volved. Experiments using various ATP-receptor ago-
nists raised the possibility that ATP may induce myelina-tion through a novel mechanism, which potentially
involved cytokines. Likely candidates that came to
mind were members of the leukimia inhibitory factor
(LIF)/CNTF family, which were previously shown to stim-
ulate myelination when added to mature cortical cocul-
tures (Stankoff et al., 2002). It turned out that Ishibashi
et al. were right: LIF was found in their cultures in a
similar age- and activity-dependent manner as ATP,
function-blocking anti-LIF antibodies abolished the pro-
myelinating effect observed, and the addition of LIF
mimicked the promotion of myelination by electrical ac-
tivity and ATP. Interestingly, myelination was increased
significantly by the addition of low concentrations of LIF,
but was inhibited at high concentrations. This biphasic
response may resolve early discrepancies reported in
the literature on the effects of this cytokine on myelina-
tion (Park et al., 2001; Stankoff et al., 2002).
What is the source of LIF? Ishibashi et al. showed that,
surprisingly, LIF was released by astrocytes that were
present in their cocultures. In agreement with a previous
study showing that activation of P2 receptors on astro-
cytes induces LIF mRNA (Yamakuni et al., 2002), the au-
thors found that the expression of LIF mRNA was upre-
gulated in response to the electrical activity of axons.
This increase was eliminated by the addition of apyrase,
an enzyme that degrades extracellular ATP, suggesting
that ATP released from electrically active neurons stim-
ulates the production and secretion of LIF from astro-
cytes, which in turn promotes oligodendrocyte myelina-
tion. LIF was also present in optic nerves during the early
phase of myelination, further supporting a role for this
cytokine in CNS myelination. Finally, by adding astro-
cytes isolated from wild-type or LIF-deficient mice to
cocultures containing DRG neurons and mature oligo-
dendrocytes, it was found that the presence of LIF-
expressing astrocytes was imperative for the activity-
dependent increase in myelination.
Strikingly, this study shows that the decision whether
an axon should be myelinated does not only depend on
the axon itself and the oligodendrocyte attached to it,
but also on the presence of an astrocyte in the close vi-
cinity. So, are astrocytes key players in the decision
whether to myelinate at all, or do they play more of
a modulating role, like the fine-tuning of the extent of
myelination? Yet another possibility is that myelination
is governed by different signals that together have to
reach a certain threshold; in such a scenario, the influ-
ence of astrocytes would be only one of several cues
that direct oligedondrocytes toward myelination. Analy-
sis of LIF-deficient mice revealed that the brains of fe-
male animals exhibit reduced amounts of GFAP-positive
astrocytes and lower levels of MBP (Bugga et al., 1998).
Thus, although astrocytes and astrocyte-derived LIF ap-
pear to have an important function in CNS myelination,
myelin could nonetheless still be formed in the absence
of LIF, indicating that this cytokine has a modulatory role
in this process. This notion is further supported by ob-
servations made using GFAP null mice, which exhibit
various late-onset white matter aberrations, including
ongoing myelination by oligodendrocytes in adult
Picking out the Details
of Cerebellar LTD
Cerebellar long-term depression is thought to underlie
motor learning and is mediated by internalization of
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778animals and demyelination (Liedtke et al., 1996). Inter-
estingly, myelin abnormalities are also the hallmarks of
Alexander disease (AxD), a disorder caused by domi-
nant, usually sporadic mutations in the gfap gene. The
results presented by Ishibashi et al. may suggest that
the myelin defects seen in gfap deficiency are second-
ary effects caused by impaired astrocyte physiology
leading to deregulation of astrocyte-derived myelination
signals.
A question arising from the current study is whether
the regulation of myelination by electrical activity occurs
only at the onset of myelination or whether it also plays
a role in mature myelinated nerves. The later possibility
is tempting, as it could explain whether and how the in-
sulating properties of the myelin sheath (e.g., the num-
ber of myelin wraps) are adapted to the electrical activity
of the underlying axon; such activity-dependent plastic-
ity of myelin formation was suggested in the past but
was not proven experimentally. Mechanisms where
electrical activity is represented in cellular cytoarchitec-
ture are well described in CNS synapses. Interestingly,
astrocytes also have important functions in synapse
physiology, including synapse formation, the control of
their number, and in fine-tuning of synaptic strength
(Volterra and Meldolesi, 2005).
A general scheme is beginning to emerge of how mye-
lination is initiated (Figure 1). Target innervation by the
axons leads to increased electrical activity and axon-
glia communication, effecting a change in the expres-
sion of various molecules on both the axonal membrane
and oligodendrocyte processes. An important conse-
Figure 1. Regulatory Steps during the Initiation of Myelination
Increase in electrical activity in axons after target innervation
(1) causes the release of promyelinating factors (2) that act directly or
indirectly through astrocytes on oligodendrocytes. Concomitantly,
axons downregulate the expression of inhibitory cell-adhesion mol-
ecules (3) and upregulate other membrane-bound molecules that
are required for ensheathment (2). The multiple axonal-oligodendro-
cyte signals (4) result in the production of molecules that mediate
axon-glia interaction (5) and myelination.quence of this communication is a dramatic change in
the expression of cell-adhesion molecules, which may
drive myelination and establish specialized functional
domains at and around the node of Ranvier that are nec-
essary for proper saltatory conduction (Poliak and
Peles, 2003). For example, electrical activity was shown
to regulate the expression of two axonal members of the
immunoglobulin superfamily of cell-adhesion molecules
(IgSF-CAMs) that were implicated in myelination: poly-
sialated NCAM (PSA-NCAM), whose disappearance
was found to be a prerequisite for myelination to com-
mence, and axonal L1, which is required for the align-
ment of glial processes with the underlying axon (Coman
et al., 2005). Given the large number of cell surface mol-
ecules that are expressed by myelinating glia (Spiegel
et al., 2006), the effect of electrical activity and the sur-
prising involvement of astrocytes in regulating myelina-
tion (Ishibashi et al., 2006), it seems that the molecular
mechanisms controlling this process are only starting
to come into light.
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